| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 227 | 522,199 | IVE, IVW, IEFA, IJS | 13F-HR | 10/16/2024 | 000108514624004959 |
| Q2 2024 | 207 | 482,684 | IVE, IVW, IEFA, IJS | 13F-HR | 8/14/2024 | 000108514624003951 |
| Q1 2024 | 209 | 483,552 | IVE, IVW, IJS, IEFA | 13F-HR | 5/2/2024 | 000108514624002189 |
| Q4 2023 | 202 | 459,003 | IVE, IVW, IJS, IEFA | 13F-HR | 2/12/2024 | 000108514624001062 |
| Q3 2023 | 179 | 433,692 | IVE, IVW, SLQD, IJS | 13F-HR | 11/14/2023 | 000108514623004402 |
| Q2 2023 | 188 | 457,986 | IVE, IVW, SLQD, IJS | 13F-HR | 8/10/2023 | 000108514623003229 |
| Q4 2022 | 182 | 441,493 | IVE, IVW, SLQD, IJS | 13F-HR | 2/14/2023 | 000108514623001380 |
| Q3 2022 | 171 | 402,911 | IVE, IVW, SLQD, IJS | 13F-HR | 11/14/2022 | 000108514622003949 |
| Q2 2022 | 177 | 431,817 | IVE, IVW, SLQD, IJS | 13F-HR | 8/12/2022 | 000108514622003015 |
| Q1 2022 | 186 | 484,656 | IVE, IVW, IJS, SLQD | 13F-HR | 5/10/2022 | 000108514622001930 |
| Q4 2021 | 196 | 505,570 | IVE, IVW, IJS, SLQD | 13F-HR | 2/10/2022 | 000108514622000806 |
| Q3 2021 | 203 | 484,048 | IVE, IVW, IJS, SLQD | 13F-HR | 10/7/2021 | 000108514621002682 |
| Q2 2021 | 199 | 474,875 | IVE, IVW, IJS, SLQD | 13F-HR | 8/5/2021 | 000108514621002256 |
| Q1 2021 | 195 | 447,751 | IVE, IVW, IJS, SLQD | 13F-HR | 4/28/2021 | 000108514621001351 |
| Q3 2020 | 181 | 353,452 | IVW, IVE, SLQD, IJS | 13F-HR | 11/9/2020 | 000108514620002808 |
| Q2 2020 | 168 | 322,750 | IVW, IVE, SLQD, IJS | 13F-HR | 8/3/2020 | 000108514620001971 |
| Q1 2020 | 162 | 272,179 | IVE, IVW, SLQD, IJS | 13F-HR | 5/15/2020 | 000108514620001598 |
| Q4 2019 | 178 | 330,902 | IVE, IVW, IJS, SLQD | 13F-HR | 2/13/2020 | 000108514620000623 |
| Q3 2019 | 172 | 308,134 | IVE, IVW, IJS, SLQD | 13F-HR | 11/14/2019 | 000108514619002991 |
| Q2 2019 | 169 | 301,224 | IVE, IVW, IJS, SLQD | 13F-HR | 8/8/2019 | 000108514619002144 |
| Q1 2019 | 164 | 290,846 | IVE, IVW, IJS, SLQD | 13F-HR | 4/29/2019 | 000108514619001275 |
| Q4 2018 | 155 | 269,490 | IVE, IVW, IJS, SLQD | 13F-HR | 2/12/2019 | 000108514619000593 |
| Q3 2018 | 157 | 307,981 | IVE, IVW, IJS, IEFA | 13F-HR | 11/14/2018 | 000108514618002728 |
| Q2 2018 | 161 | 284,332 | IVE, IVW, IJS, IEFA | 13F-HR | 8/13/2018 | 000108514618002000 |
| Q1 2018 | 155 | 288,758 | IVE, IVW, IJS, IGSB | 13F-HR | 4/16/2018 | 000108514618001082 |
| Q4 2017 | 156 | 285,981 | IJS, IVE, IVW, IGSB | 13F-HR | 2/9/2018 | 000108514618000437 |
| Q3 2017 | 141 | 268,795 | IJS, IVE, IGSB, IVW | 13F-HR | 10/27/2017 | 000108514617002140 |
| Q2 2017 | 139 | 264,919 | IJS, IVE, IGSB, IVW | 13F-HR | 7/27/2017 | 000108514617001575 |
| Q1 2017 | 138 | 257,919 | IJS, IVE, IGSB, IVW | 13F-HR | 5/11/2017 | 000108514617001179 |
| Q4 2016 | 132 | 237,813 | IJS, IVE, IGSB, IVW | 13F-HR | 2/2/2017 | 000108514617000254 |
| Q3 2016 | 136 | 231,786 | IJS, IGSB, IVE, IVW | 13F-HR | 11/7/2016 | 000108514616004661 |
| Q2 2016 | 131 | 223,215 | IJS, IGSB, IVE, IVW | 13F-HR | 8/15/2016 | 000108514616004309 |